Author(s) Details:
R Shibu
Department of Orthopaedics, Government Medical College, Thiruvananthapuram, Kerala-695011, India.
Shan AK
Department of Orthopaedics, Government Medical College, Thiruvananthapuram, Kerala-695011, India.
Akhil Kumar K
Department of Orthopaedics, Government Medical College, Thiruvananthapuram, Kerala-695011, India.
Binoy S
Department of Orthopaedics, Government Medical College, Thiruvananthapuram, Kerala-695011, India.
This section is a part of the chapter: Management of Charcot Neuroarthropathy of Foot with Hindfoot Retrograde Intramedullary Nail
Charcot neuroarthropathy (CN) is a non-infective, destructive process occurring in patients rendered insensate by peripheral neuropathy, which is caused mainly by diabetes. Repetitive trauma from standing and walking provides a neuro-traumatic stimulus that leads to dislocation, or peri-articular fracture, or both, within the ankle (Galhoum et al., 2021; Gökosmanoğlu et al., 2016). CN of foot was first described by Jean Martin Charcot in 1868 in association with tabes dorsalis resulting from tertiary syphilis. Jordan in 1936, first noted its relationship to diabetes, which is now recognized as the main cause of Charcot foot. It develops in 1 per 600 diabetic patients and in 1 per 100 patients with diabetic neuropathy (Ersin et al., 2020; Rosskopf et al., 2019; Sponer et al., 2013). In diabetes, CN signifies a patent clinical presentation indicated by impaired proprioception, autonomic dysfunction, and profound sensory neuropathy.
How to Cite
Shibu, R., AK, S., K, A. K., & S, B. (2025). Management of Charcot Neuroarthropathy of Foot with Hindfoot Retrograde Intramedullary Nail. Medical Science: Trends and Innovations Vol. 4, 152–170. https://doi.org/10.9734/bpi/msti/v4/4184